Linda Morrow Selected Research

Insulin Resistance

1/2022	Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteers.
1/2018	Bimagrumab improves body composition and insulin sensitivity in insulin-resistant individuals.
8/2016	Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes.
9/2013	Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda Morrow Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2021 - 07/2011
5	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 03/2011
4	Insulin Resistance 01/2022 - 09/2013
4	Body Weight (Weight, Body) 11/2020 - 01/2014
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 03/2011
2	Non-alcoholic Fatty Liver Disease 01/2021 - 09/2013
2	Obesity 11/2020 - 01/2018
2	Weight Loss (Weight Reduction) 11/2020 - 09/2013
2	Overweight 11/2020 - 01/2019
2	Candidiasis (Moniliasis) 01/2014 - 01/2014
1	Schizophrenia (Dementia Praecox) 01/2022
1	Hyperinsulinism (Hyperinsulinemia) 01/2022
1	Weight Gain 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hyperglycemia 01/2018
1	Dyslipidemias (Dyslipidemia) 08/2016
1	Pain (Aches) 07/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2013
1	Diabetes Mellitus 07/2011

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2011
9	Insulin (Novolin)FDA Link 01/2022 - 03/2011
3	CanagliflozinIBA 10/2014 - 01/2014
3	SodiumIBA 10/2014 - 01/2014
3	SymportersIBA 10/2014 - 01/2014
2	InsulinsIBA 01/2022 - 03/2011
2	Metformin (Glucophage)FDA LinkGeneric 10/2014 - 01/2014
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 03/2012 - 03/2011
2	Insulin Lispro (Humalog)FDA Link 03/2012 - 03/2011
1	C-PeptideIBA 01/2022
1	3-carboxamido-4-hydroxynaltrexoneIBA 01/2022
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	efpeglenatideIBA 01/2021
1	Liraglutide FDA Link 01/2021
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	fibroblast growth factor 21IBA 11/2020
1	AdiponectinIBA 11/2020
1	CarbohydratesIBA 11/2020
1	Soluble Guanylyl CyclaseIBA 01/2020
1	praliciguatIBA 01/2020
1	LDL CholesterolIBA 01/2019
1	Proprotein Convertase 9IBA 01/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	MK-2640IBA 01/2019
1	MK-1293IBA 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018
1	Prostaglandin D2IBA 01/2018
1	bimagrumabIBA 01/2018
1	AlbuminsIBA 08/2016
1	ApolipoproteinsIBA 08/2016
1	ISIS 304801IBA 08/2016
1	Triglycerides (Triacylglycerol)IBA 08/2016
1	FructosamineIBA 08/2016
1	Apolipoprotein C-IIIIBA 08/2016
1	insulin degludecIBA 04/2014
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2014
1	(1- (3- isopropyl- 1,2,4- oxadiazol- 5- yl)piperidin- 4- yl)methyl methanesulfonateIBA 01/2014
1	Hormones (Hormone)IBA 01/2014
1	LipidsIBA 09/2013
1	EnzymesIBA 09/2013
1	Bile Acids and Salts (Bile Acids)IBA 09/2013
1	Alanine Transaminase (SGPT)IBA 09/2013
1	obeticholic acidIBA 09/2013
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2012

Therapy/Procedure

3	Glycemic Control 01/2022 - 03/2011
2	Therapeutics 11/2020 - 01/2020
2	Injections 07/2015 - 03/2011
1	Ostomy 07/2021
1	Aftercare (After-Treatment) 08/2016
1	Intramuscular Injections 07/2015
1	Subcutaneous Injections 03/2012